Influence of metabolic syndrome factors and insulin resistance on the efficacy of ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome and atherosclerotic coronary heart disease risk-Reference-Cited by-同舟云学术

Influence of metabolic syndrome factors and insulin resistance on the efficacy of ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome and atherosclerotic coronary heart disease risk

Published:2015-09-04 Issue:1 Volume:14 Page:
ISSN:1476-511X
Container-title:Lipids in Health and Disease
language:en
Short-container-title:Lipids Health Dis

Author:

Rosen Jeffrey B.,Ballantyne Christie M.,Hsueh Willa A.,Lin Jianxin,Shah Arvind K.,Lowe Robert S.,Tershakovec Andrew M.

Funder

Merck & Co., Inc., Kenilworth, NJ

Publisher

Springer Science and Business Media LLC

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1186/s12944-015-0075-5.pdf

Reference30 articles.

1. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–52.

2. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56:1113–32.

3. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, et al. The Metabolic Syndrome. Endocr Rev. 2008;29:777–822.

4. Grundy SM. Controversy in clinical endocrinology - Metabolic syndrome: A multiplex cardiovascular risk factor. J Clin Endocrinol Metab. 2007;92:399–404.

5. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008;28:629–36.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ASPROSIN AND ITS RELATIONSHIP TO INSULIN RESISTANCE IN METABOLIC SYNDROME;Military Medical Science Letters;2023-12-01

2. Phloridzin Ameliorates Lipid Deposition in High-Fat-Diet-Fed Mice with Nonalcoholic Fatty Liver Disease via Inhibiting the mTORC1/SREBP-1c Pathway;Journal of Agricultural and Food Chemistry;2021-08-03

3. Pathogenesis, Diagnosis, and Management of Metabolic Syndrome: A Comprehensive Review;SBV Journal of Basic, Clinical and Applied Health Science;2021

4. Metabolic syndrome is associated with increased cardiac morbidity after infrainguinal bypass surgery irrespective of the use of cardiovascular risk-modifying agents;Journal of Vascular Surgery;2019-01

5. COSMIC project: consensus on the objectives of the metabolic syndrome in clinic;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2018-10